In another study, High-protein intake stimulates postprandial GLP1 and PYY release (Faroqui et al., 2012), protein was shown to stimulate GLP-1 more than fat and carbohydrates
Secondary and exploratory outcomes showed improvements in systolic blood pressure (710 mmHg), triglycerides, and liver enzymes, suggesting potential benefits beyond glycaemic control, though these are not licensed indications
doi: 10.1530/EJE-14-0845 149 MinLHodiFSGiobbie-HurderAOttPALukeJJDonahueHet al
As covered in BUSINESS TODAY Generic semaglutide hits India prices fall 90% as companies compete for patients Read article BLOOMBERG Generic Ozempic to launch in India at $14 as patent expires for GLP-1 drugs Read article BUSINESS STANDARD Dr Reddy's enters semaglutide market, launches diabetes generic drug Obeda Read article NEW ENGLAND JOURNAL OF MEDICINE Semaglutide and cardiovascular outcomes in obesity without diabetes SELECT Trial Read article NATURE MEDICINE Long-term weight loss effects of semaglutide 10.2% sustained over 4 years Read article WHO WHO issues global guideline on GLP-1 medicines for treatment of obesity in adults Read article STAT NEWS Semaglutide is going off-patent in India but will people who need it be able to get it
Baseline and follow-up readings give a measurable signal
